Rolofylline: a selective adenosine 1 receptor antagonist for the treatment of heart failure

Author： Slawsky Mara T   Givertz Michael M  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.2, 2009-02, pp. : 311-322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Safety of an Adenosine A 1 -Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment: Findings from PROTECT

By Teerlink John R.  

Drug Safety, Vol. 35, Iss. 3, 2012-03 ,pp. : 233-244

Adis International

Access to resources Recommend Favorite

BG 9928, an oral A1 adenosine antagonist, shows promise for patients with heart failure

By  

Inpharma, Vol. 1, Iss. 1601, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

A novel non-xanthine adenosine A 1 receptor antagonist

By Terai T.   Kita Y.   Kusunoki T.   Shimazaki T.   Ando T.   Horiai H.   Akahane A.   Shiokawa Y.   Yoshida K.  

European Journal of Pharmacology, Vol. 279, Iss. 2, 1995-06 ,pp. : 217-225

Elsevier

Access to resources Recommend Favorite

EARTH: EndothelinA Receptor Antagonist Trial in Heart Failure

By  

Heart Drug, Vol. 1, Iss. 6, 2002-02 ,pp. : 294-298

Karger

Access to resources Recommend Favorite

Repeated treatment with adenosine A 1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene

By De Sarro G.   Donato Di Paola E.   Falconi U.   Ferreri G.   De Sarro A.  

European Journal of Pharmacology, Vol. 317, Iss. 2, 1996-12 ,pp. : 239-245

Elsevier

Access to resources Recommend Favorite